MV, M., E, Z., M, G., R, H., F, L., ML, R., . . . M, M. (2026). European Recommendations for Transitioning the Care of Patients With Multiple Myeloma Treated With B-Cell Maturation Antigen Bispecific Antibodies From Academic Hospitals to Community-Based Centers and for Outpatient Step-Up Dosing. EJHaem, 7, e70290. https://doi.org/10.1002/jha2.70290
Chicago Style (17th ed.) CitationMV, Mateos, et al. "European Recommendations for Transitioning the Care of Patients With Multiple Myeloma Treated With B-Cell Maturation Antigen Bispecific Antibodies From Academic Hospitals to Community-Based Centers and for Outpatient Step-Up Dosing." EJHaem 7 (2026): e70290. https://doi.org/10.1002/jha2.70290.
MLA (9th ed.) CitationMV, Mateos, et al. "European Recommendations for Transitioning the Care of Patients With Multiple Myeloma Treated With B-Cell Maturation Antigen Bispecific Antibodies From Academic Hospitals to Community-Based Centers and for Outpatient Step-Up Dosing." EJHaem, vol. 7, 2026, p. e70290, https://doi.org/10.1002/jha2.70290.
